These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Exhaled nitric oxide levels to guide treatment for children with asthma. Petsky HL; Kew KM; Chang AB Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189 [TBL] [Abstract][Full Text] [Related]
23. Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms. Debley JS; Cochrane ES; Redding GJ; Carter ER Ann Allergy Asthma Immunol; 2012 Aug; 109(2):114-20. PubMed ID: 22840252 [TBL] [Abstract][Full Text] [Related]
24. Acinar effect of inhaled steroids evidenced by exhaled nitric oxide. Van Muylem A; Kerckx Y; Michils A J Allergy Clin Immunol; 2010 Oct; 126(4):730-735.e2. PubMed ID: 20709384 [TBL] [Abstract][Full Text] [Related]
25. Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E(4) in children with mild asthma. Steiss JO; Rudloff S; Landmann E; Rückes-Nilges C; Zimmer KP; Lindemann H Allergy Asthma Proc; 2008; 29(4):371-5. PubMed ID: 18702883 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma. Corren J; Tashkin DP Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702 [TBL] [Abstract][Full Text] [Related]
27. Serum and exhaled breath condensate leptin levels in asthmatic and obesity children: a pilot study. Bodini A; Tenero L; Sandri M; Maffeis C; Piazza M; Zanoni L; Peroni D; Boner A; Piacentini G J Breath Res; 2017 Sep; 11(4):046005. PubMed ID: 28952460 [TBL] [Abstract][Full Text] [Related]
28. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183 [TBL] [Abstract][Full Text] [Related]
29. Factors associated with exhaled nitric oxide in children with asthma and allergic rhinitis. Zhu Z; Xia S; Chen X; Guan WJ; Guo ZJ; Sun BQ Clin Respir J; 2020 Jan; 14(1):9-15. PubMed ID: 31602812 [TBL] [Abstract][Full Text] [Related]
30. Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO). Turner S; Cotton SC; Emele CD; Thomas R; Fielding S; Gaillard EA; de Jongste JC; Morgan H; Neilson AR; Norrie J; Pijnenburg M; Price D; Thomas M Trials; 2019 Oct; 20(1):573. PubMed ID: 31585544 [TBL] [Abstract][Full Text] [Related]
31. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Bisgaard H; Loland L; Oj JA Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811 [TBL] [Abstract][Full Text] [Related]
32. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Pijnenburg MW; Bakker EM; Lever S; Hop WC; De Jongste JC Clin Exp Allergy; 2005 Jul; 35(7):920-5. PubMed ID: 16008679 [TBL] [Abstract][Full Text] [Related]
33. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Brenner BE; Chavda KK; Camargo CA Ann Emerg Med; 2000 Nov; 36(5):417-26. PubMed ID: 11054193 [TBL] [Abstract][Full Text] [Related]